PDC-APB

N/A

Report date: 2024/11/24 20:00:04
NME

Base Information

Drug NamePDC-APB
Drug Alias NamePDCAPBHPT-721
ClassificationSmall moleculesNatural product/Extract
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsDermatitis, Contact
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Mississippi
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHapten Sciences Inc
Active IndicationsN/A
Inactive IndicationsDermatitis, Contact

Other Information

ATC CodeN/A
Related LinksN/A